BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28512773)

  • 21. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging.
    Murayama S; Kimura W; Hirai I; Takasu N; Takeshita A; Moriya T
    Pancreas; 2011 Aug; 40(6):876-82. PubMed ID: 21747312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
    Mandai K; Uno K; Yasuda K
    Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-Term Outcomes and Risk of Pancreatic Cancer in Intraductal Papillary Mucinous Neoplasms.
    de la Fuente J; Chatterjee A; Lui J; Nehra AK; Bell MG; Lennon RJ; Kassmeyer BA; Graham RP; Nagayama H; Schulte PJ; Doering KA; Delgado AM; Vege SS; Chari ST; Takahashi N; Majumder S
    JAMA Netw Open; 2023 Oct; 6(10):e2337799. PubMed ID: 37847503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observational study of the incidence of pancreatic and extrapancreatic malignancies during surveillance of patients with branch-duct intraductal papillary mucinous neoplasm.
    Malleo G; Marchegiani G; Borin A; Capelli P; Accordini F; Butturini G; Pederzoli P; Bassi C; Salvia R
    Ann Surg; 2015 May; 261(5):984-90. PubMed ID: 25493361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk Factors for Pancreatic Cancer and the Necessity of Long-Term Surveillance in Patients With Pancreatic Cystic Lesions.
    Yoshioka T; Shigekawa M; Ikezawa K; Tamura T; Sato K; Urabe M; Sueyoshi H; Yamai T; Suda T; Sakamori R; Tatsumi T; Takehara T
    Pancreas; 2020 Apr; 49(4):552-560. PubMed ID: 32282769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of neoplastic pancreatic cysts without high-risk stigmata: how often do we change treatment strategy because of malignant transformation?
    Lekkerkerker SJ; Besselink MG; Busch OR; Dijk F; Engelbrecht MR; Rauws EA; Fockens P; van Hooft JE
    Scand J Gastroenterol; 2016 Sep; 51(9):1138-43. PubMed ID: 27175891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.
    Sahora K; Mino-Kenudson M; Brugge W; Thayer SP; Ferrone CR; Sahani D; Pitman MB; Warshaw AL; Lillemoe KD; Fernandez-del Castillo CF
    Ann Surg; 2013 Sep; 258(3):466-75. PubMed ID: 24022439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging morphological changes of intraductal papillary mucinous neoplasm of the pancreas was associated with its malignant transformation but not with development of pancreatic ductal adenocarcinoma.
    Kawada N; Uehara H; Nagata S; Tsuchishima M; Tsutsumi M; Tomita Y
    Pancreatology; 2015; 15(6):654-60. PubMed ID: 26433405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [CT diagnosis of intraductal papillary mucinous tumor of the pancreas].
    Wang DQ; Ji Y; Shi X; Rao SX; Ye T; Jin DY; Lou WH; Zeng MS
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):606-8. PubMed ID: 17236556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk for mortality from causes other than pancreatic cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
    Kawakubo K; Tada M; Isayama H; Sasahira N; Nakai Y; Takahara N; Miyabayashi K; Yamamoto K; Mizuno S; Mohri D; Kogure H; Sasaki T; Yamamoto N; Tateishi R; Hirano K; Ijichi H; Tateishi K; Koike K
    Pancreas; 2013 May; 42(4):687-91. PubMed ID: 23211374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT attenuation of unilocular pancreatic cystic lesions to differentiate pseudocysts from mucin-containing cysts.
    Chalian H; Töre HG; Miller FH; Yaghmai V
    JOP; 2011 Jul; 12(4):384-8. PubMed ID: 21737901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the American Gastroenterological Association guidelines on management of intraductal papillary mucinous neoplasms: more than 5 years of follow-up.
    Imbe K; Nagata N; Hisada Y; Takasaki Y; Sekine K; Mishima S; Kawazoe A; Tajima T; Shimbo T; Yanase M; Akiyama J; Fujimoto K; Uemura N
    Eur Radiol; 2018 Jan; 28(1):170-178. PubMed ID: 28770404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A resected case of two branch duct-type intraductal papillary mucinous neoplasms showing different clinical courses after a two-year follow-up.
    Shibata H; Ohike N; Norose T; Isobe T; Suzuki R; Imai H; Shiokawa A; Takimoto M; Tabuchi A; Takano Y; Yamamura E; Nagahama M; Takeyama N; Yokomizo K; Mizukami H; Tanaka JI; Aoki T; Murakami M
    Clin J Gastroenterol; 2017 Jun; 10(3):274-278. PubMed ID: 28258561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Branch duct intraductal papillary mucinous neoplasm of the pancreas in solid organ transplant recipients.
    Gill KR; Pelaez-Luna M; Keaveny A; Woodward TA; Wallace MB; Chari ST; Smyrk TC; Takahashi N; Clain JE; Levy MJ; Pearson RK; Petersen BT; Topazian MD; Vege SS; Kendrick M; Farnell MB; Raimondo M
    Am J Gastroenterol; 2009 May; 104(5):1256-61. PubMed ID: 19352341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms.
    Tanno S; Nakano Y; Koizumi K; Sugiyama Y; Nakamura K; Sasajima J; Nishikawa T; Mizukami Y; Yanagawa N; Fujii T; Okumura T; Obara T; Kohgo Y
    Pancreas; 2010 Jan; 39(1):36-40. PubMed ID: 19745777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic neuroendocrine tumors among patients with intraductal papillary mucinous neoplasms: real association or just a coincidence?
    Gill KR; Scimeca D; Stauffer J; Krishna M; Woodward TA; Jamil LH; Wallace MB; Nguyen JH; Raimondo M
    JOP; 2009 Sep; 10(5):515-7. PubMed ID: 19734627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.